Email
Print
Biosimilar Testing And Development Services Market - Forecast(2024 - 2030)
1. Biosimilar Testing And Development Services Market - Overview
1.1 Definitions and Scope
2. Biosimilar Testing And Development Services Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Biosimilar Testing And Development Services Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Biosimilar Testing And Development Services Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Biosimilar Testing And Development Services Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Biosimilar Testing And Development Services Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Biosimilar Testing And Development Services Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Biosimilar Testing And Development Services Market - By Type (Market Size -$Million / $Billion)
11.1 Biosimilar Testing And Development Services Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Biosimilar Testing And Development Services- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Biosimilar Testing And Development Services- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Biosimilar Testing And Development Services - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Biosimilar Testing And Development Services - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Biosimilar Testing And Development Services Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Biosimilar Testing And Development Services Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Biosimilar Testing And Development Services Market - Key Company List by Country Premium
15. Biosimilar Testing And Development Services Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Charles River Laboratory International Inc
15.3 Eurofins Scientific
15.4 Exova Group Plc
15.5 Intertek Group Plc
15.6 Medistri Sa
15.7 Pace Analytical Service Inc
15.8 Pharmaceutical Product Development, Llc
15.9 Sg Sa
15.10 Sigma-Aldrich Co. Llc
15.11 Source Bioscience Plc
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Biosimilar Testing And Development Services Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
1.1 Definitions and Scope
2. Biosimilar Testing And Development Services Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Biosimilar Testing And Development Services Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Biosimilar Testing And Development Services Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Biosimilar Testing And Development Services Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Biosimilar Testing And Development Services Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Biosimilar Testing And Development Services Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Biosimilar Testing And Development Services Market - By Type (Market Size -$Million / $Billion)
9. Biosimilar Testing And Development Services Market - By Clinical Assay (Market Size -$Million / $Billion)
9.1 Pk Assay
9.2 Tiered Immunogenicity Testing
9.3 Nab Assay
10. Biosimilar Testing And Development Services - By Comparability Testing (Market Size -$Million / $Billion)
10.1 Effector Binding Biacore
10.1.1 Fcri
10.1.2 Fcrii
10.1.3 Fcriii
10.1.4 Fcrn
10.2 C1Q Binding By Elisa
10.3 Kinetic Binding Assay By Biacore
10.4 Adcc And Cdc Assay Cell Based Assay
11. Biosimilar Testing And Development Services- By Geography (Market Size -$Million / $Billion)11.1 Biosimilar Testing And Development Services Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Biosimilar Testing And Development Services- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Biosimilar Testing And Development Services- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Biosimilar Testing And Development Services - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Biosimilar Testing And Development Services - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Biosimilar Testing And Development Services Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Biosimilar Testing And Development Services Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Biosimilar Testing And Development Services Market - Key Company List by Country Premium
15. Biosimilar Testing And Development Services Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Charles River Laboratory International Inc
15.3 Eurofins Scientific
15.4 Exova Group Plc
15.5 Intertek Group Plc
15.6 Medistri Sa
15.7 Pace Analytical Service Inc
15.8 Pharmaceutical Product Development, Llc
15.9 Sg Sa
15.10 Sigma-Aldrich Co. Llc
15.11 Source Bioscience Plc
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Biosimilar Testing And Development Services Market - Appendix16.1 Abbreviations
16.2 Sources
17. Biosimilar Testing And Development Services Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Global Biosimilar Testing And Development Service Market, By Clinical Assay Market 2023-2030 ($M)1.1 Pk Assay Market 2023-2030 ($M) - Global Industry Research
1.2 Tiered Immunogenicity Testing Market 2023-2030 ($M) - Global Industry Research
1.3 Nab Assay Market 2023-2030 ($M) - Global Industry Research
2.Global Global Biosimilar Testing And Development Service Market, By Comparability Testing Market 2023-2030 ($M)
2.1 Effector Binding Biacore Market 2023-2030 ($M) - Global Industry Research
2.1.1 Fcri Market 2023-2030 ($M)
2.1.2 Fcrii Market 2023-2030 ($M)
2.1.3 Fcriii Market 2023-2030 ($M)
2.1.4 Fcrn Market 2023-2030 ($M)
2.2 C1Q Binding By Elisa Market 2023-2030 ($M) - Global Industry Research
2.3 Kinetic Binding Assay By Biacore Market 2023-2030 ($M) - Global Industry Research
2.4 Adcc And Cdc Assay Cell Based Assay Market 2023-2030 ($M) - Global Industry Research
3.Global Global Biosimilar Testing And Development Service Market, By Clinical Assay Market 2023-2030 (Volume/Units)
3.1 Pk Assay Market 2023-2030 (Volume/Units) - Global Industry Research
3.2 Tiered Immunogenicity Testing Market 2023-2030 (Volume/Units) - Global Industry Research
3.3 Nab Assay Market 2023-2030 (Volume/Units) - Global Industry Research
4.Global Global Biosimilar Testing And Development Service Market, By Comparability Testing Market 2023-2030 (Volume/Units)
4.1 Effector Binding Biacore Market 2023-2030 (Volume/Units) - Global Industry Research
4.1.1 Fcri Market 2023-2030 (Volume/Units)
4.1.2 Fcrii Market 2023-2030 (Volume/Units)
4.1.3 Fcriii Market 2023-2030 (Volume/Units)
4.1.4 Fcrn Market 2023-2030 (Volume/Units)
4.2 C1Q Binding By Elisa Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Kinetic Binding Assay By Biacore Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Adcc And Cdc Assay Cell Based Assay Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America Global Biosimilar Testing And Development Service Market, By Clinical Assay Market 2023-2030 ($M)
5.1 Pk Assay Market 2023-2030 ($M) - Regional Industry Research
5.2 Tiered Immunogenicity Testing Market 2023-2030 ($M) - Regional Industry Research
5.3 Nab Assay Market 2023-2030 ($M) - Regional Industry Research
6.North America Global Biosimilar Testing And Development Service Market, By Comparability Testing Market 2023-2030 ($M)
6.1 Effector Binding Biacore Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Fcri Market 2023-2030 ($M)
6.1.2 Fcrii Market 2023-2030 ($M)
6.1.3 Fcriii Market 2023-2030 ($M)
6.1.4 Fcrn Market 2023-2030 ($M)
6.2 C1Q Binding By Elisa Market 2023-2030 ($M) - Regional Industry Research
6.3 Kinetic Binding Assay By Biacore Market 2023-2030 ($M) - Regional Industry Research
6.4 Adcc And Cdc Assay Cell Based Assay Market 2023-2030 ($M) - Regional Industry Research
7.South America Global Biosimilar Testing And Development Service Market, By Clinical Assay Market 2023-2030 ($M)
7.1 Pk Assay Market 2023-2030 ($M) - Regional Industry Research
7.2 Tiered Immunogenicity Testing Market 2023-2030 ($M) - Regional Industry Research
7.3 Nab Assay Market 2023-2030 ($M) - Regional Industry Research
8.South America Global Biosimilar Testing And Development Service Market, By Comparability Testing Market 2023-2030 ($M)
8.1 Effector Binding Biacore Market 2023-2030 ($M) - Regional Industry Research
8.1.1 Fcri Market 2023-2030 ($M)
8.1.2 Fcrii Market 2023-2030 ($M)
8.1.3 Fcriii Market 2023-2030 ($M)
8.1.4 Fcrn Market 2023-2030 ($M)
8.2 C1Q Binding By Elisa Market 2023-2030 ($M) - Regional Industry Research
8.3 Kinetic Binding Assay By Biacore Market 2023-2030 ($M) - Regional Industry Research
8.4 Adcc And Cdc Assay Cell Based Assay Market 2023-2030 ($M) - Regional Industry Research
9.Europe Global Biosimilar Testing And Development Service Market, By Clinical Assay Market 2023-2030 ($M)
9.1 Pk Assay Market 2023-2030 ($M) - Regional Industry Research
9.2 Tiered Immunogenicity Testing Market 2023-2030 ($M) - Regional Industry Research
9.3 Nab Assay Market 2023-2030 ($M) - Regional Industry Research
10.Europe Global Biosimilar Testing And Development Service Market, By Comparability Testing Market 2023-2030 ($M)
10.1 Effector Binding Biacore Market 2023-2030 ($M) - Regional Industry Research
10.1.1 Fcri Market 2023-2030 ($M)
10.1.2 Fcrii Market 2023-2030 ($M)
10.1.3 Fcriii Market 2023-2030 ($M)
10.1.4 Fcrn Market 2023-2030 ($M)
10.2 C1Q Binding By Elisa Market 2023-2030 ($M) - Regional Industry Research
10.3 Kinetic Binding Assay By Biacore Market 2023-2030 ($M) - Regional Industry Research
10.4 Adcc And Cdc Assay Cell Based Assay Market 2023-2030 ($M) - Regional Industry Research
11.APAC Global Biosimilar Testing And Development Service Market, By Clinical Assay Market 2023-2030 ($M)
11.1 Pk Assay Market 2023-2030 ($M) - Regional Industry Research
11.2 Tiered Immunogenicity Testing Market 2023-2030 ($M) - Regional Industry Research
11.3 Nab Assay Market 2023-2030 ($M) - Regional Industry Research
12.APAC Global Biosimilar Testing And Development Service Market, By Comparability Testing Market 2023-2030 ($M)
12.1 Effector Binding Biacore Market 2023-2030 ($M) - Regional Industry Research
12.1.1 Fcri Market 2023-2030 ($M)
12.1.2 Fcrii Market 2023-2030 ($M)
12.1.3 Fcriii Market 2023-2030 ($M)
12.1.4 Fcrn Market 2023-2030 ($M)
12.2 C1Q Binding By Elisa Market 2023-2030 ($M) - Regional Industry Research
12.3 Kinetic Binding Assay By Biacore Market 2023-2030 ($M) - Regional Industry Research
12.4 Adcc And Cdc Assay Cell Based Assay Market 2023-2030 ($M) - Regional Industry Research
13.MENA Global Biosimilar Testing And Development Service Market, By Clinical Assay Market 2023-2030 ($M)
13.1 Pk Assay Market 2023-2030 ($M) - Regional Industry Research
13.2 Tiered Immunogenicity Testing Market 2023-2030 ($M) - Regional Industry Research
13.3 Nab Assay Market 2023-2030 ($M) - Regional Industry Research
14.MENA Global Biosimilar Testing And Development Service Market, By Comparability Testing Market 2023-2030 ($M)
14.1 Effector Binding Biacore Market 2023-2030 ($M) - Regional Industry Research
14.1.1 Fcri Market 2023-2030 ($M)
14.1.2 Fcrii Market 2023-2030 ($M)
14.1.3 Fcriii Market 2023-2030 ($M)
14.1.4 Fcrn Market 2023-2030 ($M)
14.2 C1Q Binding By Elisa Market 2023-2030 ($M) - Regional Industry Research
14.3 Kinetic Binding Assay By Biacore Market 2023-2030 ($M) - Regional Industry Research
14.4 Adcc And Cdc Assay Cell Based Assay Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)2.Canada Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
3.Mexico Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
4.Brazil Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
5.Argentina Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
6.Peru Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
7.Colombia Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
8.Chile Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
9.Rest of South America Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
10.UK Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
11.Germany Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
12.France Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
13.Italy Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
14.Spain Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
15.Rest of Europe Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
16.China Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
17.India Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
18.Japan Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
19.South Korea Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
20.South Africa Biosimilar Testing And Development Services Market Revenue, 2023-2030 ($M)
21.North America Biosimilar Testing And Development Services By Application
22.South America Biosimilar Testing And Development Services By Application
23.Europe Biosimilar Testing And Development Services By Application
24.APAC Biosimilar Testing And Development Services By Application
25.MENA Biosimilar Testing And Development Services By Application
26.Eurofins Scientific, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Sg Sa, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Charles River Laboratory International Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Pharmaceutical Product Development, Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Exova Group Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Source Bioscience Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Intertek Group Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Medistri Sa, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Pace Analytical Service Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Sigma-Aldrich Co. Llc, Sales /Revenue, 2015-2018 ($Mn/$Bn)